Table 3.
Best response. CR: complete remission; PR: partial remission; MR: minimal response; SD: stable disease; PD: progressive disease; NE: not evaluated; ORR: overall response rate.
| Group 1 | Group 2 | ||
| Response | (n = 15) | (n = 74) | All (n = 89) |
| Number of patients (%) | |||
|
| |||
| CR | 0 (0) | 1 (1) | 1 (1) |
| PR | 1 (7) | 4 (5) | 5 (6) |
| MR | 1 (7) | 0 (0) | 1 (1) |
| SD ≥ 6 months | 4 (27) | 12 (16) | 16 (18) |
| SD ≥ 2 and < 6 months | 1 (7) | 15 (20) | 16 (18) |
| PD | 5 (33) | 38 (51) | 43 (48) |
| NE | 3 (20) | 4 (5) | 7 (8) |
| ORR | 6.7% | 6.7% | 6.7% |
|
| |||
| Clinical benefit, CR + PR + MR + SD | |||
| ≥ 3 months | 7 (53) | 27 (36) | 34 (38) |
| ≥ 6 months | 5 (33) | 16 (23) | 21 (23) |